Following the White House’s recent announcement of price reductions and expanded coverage for GLP-1 medications like Wegovy and Zepbound, many patients searching for obesity treatments are about to ...

Wegovy is an injectable (sub-cutaneous) prescription weight loss medicine that is indicated for people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael ...

Obesity is a growing global health crisis, affecting millions of people and increasing the risk of chronic diseases like diabetes, heart disease, and stroke. However, the good news is that obesity is ...

Welcome to “Ask the Expert,” a UTHealth Houston news series where our leading experts examine pressing health challenges. In this edition, we address child obesity to support Childhood Obesity ...

Childhood obesity is a complex disease with many contributing factors, including genetics, eating patterns; physical activity ...

Scientists may have found a new way to spot early signs of obesity, which could lead to novel prevention strategies. A study published in the journal Cell Reports has discovered that people living ...

A new report led by researchers at Pennington Biomedical Research Center underscores the growing potential of precision medicine to transform how obesity is prevented, diagnosed and treated, while ...

SAN ANTONIO — The upcoming Obesity Week meeting will feature new clinical trial data for glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, along with deep dives into clinical, social, and ...

A man with pneumonia coughed for a week until bleeding in his abdominal wall made him unstable. He took no blood thinners, making the case rare. Shreveport Precautionary Boil Advisory Covers 19 ...

Goal: Make schools a national focal point for obesity prevention. Recommendation 5: Federal, state, and local government and education authorities, with support from parents, teachers, and the ...